Observational data suggest apixaban leads to fewer thromboembolic events but higher bleeding risk, highlighting the need for ...
CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...
For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...
For patients with nonvalvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use ...
Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation and high risk for stroke and bleeding, left atrial appendage occlusion was ...
Could neurofilament light chain transform risk prediction in atrial fibrillation? Learn how this biomarker links to stroke ...
We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...
Atrial fibrillation treatment with device closure matched anticoagulants and reduced bleeding risk. Discover what this means for AF care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results